Thromboelastography Normal Reference Values in China Hunan Province

Status Completed

Clinical Trial Summary

The purpose of this study was to establish the normal reference range of Thrombelastogram parameters in Hunan by a multicenter study, and to analyze the specificity of Thrombelastogram detection and the influence of gender, age and blood type on Thrombelastogram. The study will provide basic data and statistical basis for the establishment of normal reference range of Thrombelastogram in Hunan.

Clinical Trial Description

Thrombelastograghy (TEG) is an important test to assess the blood coagulation function to monitor the whole process of perioperative coagulation. TEG can evaluate the coagulation cascade, from platelet aggregation, clot strengthening and fibrin cross-linking to eventually clot lysis in small volume of whole blood. The reference range is one important element to influence the TEG results. At present, a number of studies have shown that reference range of TEG exists significant differences between different racial and geographic. At the same time, reagent manufacturers also suggested that each TEG laboratory should establish its own reference range. So it is important to establish our own reference range of TEG to guide the clinical blood transfusion and treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03146455
Study type	Observational
Source	The Third Xiangya Hospital of Central South University
Contact
Status	Completed
Phase
Start date	June 5, 2017
Completion date	March 10, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01912547` - Thromboelastography During Surgery for Malignant Pleural Mesothelioma	Phase 0
Completed	`NCT03674684` - ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation
Recruiting	`NCT05874843` - Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients	N/A
Withdrawn	`NCT04705701` - Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care	N/A
Not yet recruiting	`NCT04515420` - The Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain Injury
Completed	`NCT01598831` - Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy	Phase 3
Completed	`NCT04580563` - Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study	N/A
Withdrawn	`NCT04274699` - Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation
Terminated	`NCT02540434` - Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions	N/A
Completed	`NCT02203968` - Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST)	Phase 1/Phase 2
Unknown status	`NCT01854476` - Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze	Phase 2/Phase 3
Completed	`NCT00816127` - Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction	N/A
Active, not recruiting	`NCT02926274` - Transfusion Using Stored Whole Blood	N/A
Completed	`NCT05295693` - Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Not yet recruiting	`NCT04582188` - The Early Coagulopathy for the Prognosis in Sepsis
Recruiting	`NCT04528888` - Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection	Phase 3
Recruiting	`NCT05449834` - Fibrinogen Early In Severe Trauma StudY II	Phase 3
Withdrawn	`NCT04435015` - The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications	Phase 1/Phase 2
Not yet recruiting	`NCT04115722` - Coagulation Parameters in IBD Patients
Completed	`NCT01228058` - A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients	N/A